Cipher Pharmaceuticals Stock Forecast - Triple Exponential Smoothing
| CPH Stock | CAD 14.86 0.30 2.06% |
The Triple Exponential Smoothing forecasted value of Cipher Pharmaceuticals on the next trading day is expected to be 14.86 with a mean absolute deviation of 0.46 and the sum of the absolute errors of 27.34. Cipher Stock Forecast is based on your current time horizon. Although Cipher Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Cipher Pharmaceuticals' systematic risk associated with finding meaningful patterns of Cipher Pharmaceuticals fundamentals over time.
Cipher |
Cipher Pharmaceuticals Triple Exponential Smoothing Price Forecast For the 24th of November
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Cipher Pharmaceuticals on the next trading day is expected to be 14.86 with a mean absolute deviation of 0.46, mean absolute percentage error of 0.44, and the sum of the absolute errors of 27.34.Please note that although there have been many attempts to predict Cipher Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cipher Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Cipher Pharmaceuticals Stock Forecast Pattern
| Backtest Cipher Pharmaceuticals | Cipher Pharmaceuticals Price Prediction | Buy or Sell Advice |
Cipher Pharmaceuticals Forecasted Value
In the context of forecasting Cipher Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cipher Pharmaceuticals' downside and upside margins for the forecasting period are 10.86 and 18.86, respectively. We have considered Cipher Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Cipher Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Cipher Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.076 |
| MAD | Mean absolute deviation | 0.4634 |
| MAPE | Mean absolute percentage error | 0.0302 |
| SAE | Sum of the absolute errors | 27.3404 |
Predictive Modules for Cipher Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cipher Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Cipher Pharmaceuticals
For every potential investor in Cipher, whether a beginner or expert, Cipher Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cipher Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cipher. Basic forecasting techniques help filter out the noise by identifying Cipher Pharmaceuticals' price trends.Cipher Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cipher Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Cipher Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cipher Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cipher Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cipher Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cipher Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cipher Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Cipher Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cipher Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Cipher Pharmaceuticals stock market strength indicators, traders can identify Cipher Pharmaceuticals entry and exit signals to maximize returns.
Cipher Pharmaceuticals Risk Indicators
The analysis of Cipher Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cipher Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cipher stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.87 | |||
| Standard Deviation | 4.02 | |||
| Variance | 16.16 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Cipher Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cipher Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Cipher Stock
| 0.77 | AMZN | Amazon CDR | PairCorr |
| 0.64 | BNS | Bank of Nova Scotia | PairCorr |
| 0.64 | BMO | Bank of Montreal | PairCorr |
| 0.42 | RY | Royal Bank | PairCorr |
| 0.4 | TD-PFI | Toronto Dominion Bank | PairCorr |
The ability to find closely correlated positions to Cipher Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cipher Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cipher Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cipher Pharmaceuticals to buy it.
The correlation of Cipher Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cipher Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cipher Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cipher Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Cipher Stock
Cipher Pharmaceuticals financial ratios help investors to determine whether Cipher Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cipher with respect to the benefits of owning Cipher Pharmaceuticals security.